Houlihan Lokey (HLI)
Advises on transactions, restructurings, valuations, and financial opinions across global markets.
Something off on this page? Send us feedback.
Advises corporations, financial sponsors, and government agencies through Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. Corporate Finance is the largest practice, while the mix of transaction, restructuring, and valuation work spans the Americas, Europe, the Middle East, and Asia-Pacific.
Advises corporations, financial sponsors, and government agencies on transactions, restructurings, valuations, and financial opinions. Corporate Finance is the largest practice, alongside Financial Restructuring and Financial and Valuation Advisory.
Serves clients across the Americas, Europe, the Middle East, and Asia-Pacific through more than 30 offices. The platform grew through organic hiring and acquisitions that added sector expertise, technology advisory scale, and international teams.
Emphasizes independent advice, analytical rigor, senior-level involvement, and cross-practice collaboration. Revenue depends on completed transaction volume, fee levels, transaction mix, restructuring activity, and economic conditions, while professional compensation dominates the cost base.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 3, 2026 | BMO Capital | Reiterate | Rating: —Target: $211 | Target: $145 |
| Jul 30, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $193 | Target: $177 |
| Jul 30, 2026 | Goldman Sachs | Reiterate | Rating: —Target: $164 | Target: $148 |
| Jul 10, 2026 | Goldman Sachs | Target | Target: — | Target: $164 |
| Jul 9, 2026 | US Capital Advisors | Target | Target: — | Target: $187 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $797.0M · Total debt $493.0M · Total assets $3.72B · Shareholders' equity $2.26B
- Revenue
- $511.0M
- Operating income
- $78.0M
- Net income
- $78.0M
HistoryDividendAnnual yield
| Institutions | ≈ 80.65% | 56.36M shares | |
|---|---|---|---|
| 524 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 7.10% | 4.96M shares | |
| 16 holders · as of Sep 10, 2026 | |||
| Other | ≈ 12.25% | 8.56M shares | |
| remainder | |||
69.89M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 7.50% | 5.24M A | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 3.97% | 2.77M A | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 3.49% | 2.44M A | as of Jun 30, 2026 |
Kayne Anderson Rudnick Investment Management LLCInstitution | 3.47% | 2.43M A | as of Jun 30, 2026 |
Earnest Partners LLCInstitution | 3.11% | 2.17M A | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 10, 2026 | Christopher M. Crain | officer: GENERAL COUNSEL | −1,000 | $140.15 |
| Aug 3, 2026 | J. Lindsey Alley | officer: Chief Financial Officer | +4,020 | $124.52 |
| May 21, 2026 | Scott L. Beiser | director, 10 percent owner, officer: CO-CHAIRMAN | −6,265 | $150.26 |
| Apr 1, 2026 | Christopher M. Crain | officer: GENERAL COUNSEL | −500 | $143.40 |
| Feb 6, 2026 | Robert A. Schriesheim | director | −5,000 | $170.86 |
- Evercore
Independent rival in M&A, restructuring, and fairness opinions
- PJT Partners
Advisory rival in M&A, capital markets, and restructuring
- Lazard
Global rival in M&A, capital solutions, and restructuring
- Moelis & Company
Independent rival across M&A, capital markets, and restructuring
- Piper Sandler
Middle-market rival in M&A, capital advisory, and restructuring
- Perella Weinberg Partners
Independent advisory rival across M&A, financing, and restructuring
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Houlihan Lokey | $131.67 | −0.71% | $9.27B | 22.3 | 17.4 | 3.7 | −15.6% |
| Evercore | $263.85 | −1.92% | $10.41B | 15.2 | 13.8 | 2.2 | +19.2% |
| PJT Partners | $150.07 | −0.87% | $3.87B | 25.4 | 17.9 | 2.1 | +19.5% |
| Lazard | $36.51 | +0.08% | $3.55B | 17.6 | 11.4 | 1.1 | −2.7% |
| Moelis & Company | $59.23 | −2.20% | $4.49B | 21.1 | 16.9 | 2.9 | +12.1% |
| Piper Sandler | $72.99 | −1.19% | $4.99B | 17.1 | 14.7 | 2.4 | +22.2% |
| Perella Weinberg Partners | $13.35 | −0.74% | $1.32B | 44.8 | 10.6 | 1.9 | +0.8% |
| Median | 19.3 | 14.2 | 2.1 | +15.6% |